23794 Federal Register / Vol. 77, No. 77 / Friday, April 20, 2012 / Notices 

1420.3; (2) Class II passenger carriers are those 

having average annual gross transportation 

operating revenues (including interstate and 

intrastate) of less than $5 million from passenger 

motor carrier operations after applying the revenue 

deflator formula as shown in Note A of section 

1420.3. Only Class I carriers of passengers are 

required to file Annual and Quarterly Report Form 

MP–1, but Class II passenger carriers must notify 

the agency when there is a change in their 

classification or their revenues exceed the Class II 

limit. 

to file Motor Carrier Quarterly and 

Annual Reports (Form MP–1) that 

provide financial and operating data 

(see 49 U.S.C. 14123; and implementing 

FMCSA regulations at 49 CFR part 369). 

The agency uses this information to 

assess the health of the industry and 

identify industry changes that may 

affect national transportation policy. 

The data also show company financial 

stability and traffic patterns. Motor 

carriers of passengers required to 

comply with the regulations are 

classified on the basis of their annual 

gross carrier operating revenues. Under 

the Financial & Operating Statistics 

(F&OS) program the FMCSA collects 

balance sheet and income statement 

data along with information on tonnage, 

mileage, employees, transportation 

equipment, and other related data. 

The data and information collected is 

made publicly available as prescribed in 

49 CFR part 369. The regulations were 

formerly administered by the Interstate 

Commerce Commission (ICC), the 

Interstate Commerce Act, 49 U.S.C. 

11145, 49 U.S.C. 11343(d)(1) and the 

Bus Regulatory Act of 1982 and later 

transferred to the U.S. Department of 

Transportation on January 1, 1996, by 

the ICC Termination Act of 1995 

(ICCTA) (Pub. L. 104–88, 109 Stat. 803 

(Dec. 29, 1995)), now codified at 49 

U.S.C. 14123. The Secretary of 

Transportation (Secretary) transferred 

the authority to administer the F&OS 

program to the former Bureau of 

Transportation Statistics on September 

30, 1998 (63 FR 52192). Pursuant to this 

authority, the BTS, now part of the 

Research and Innovative Technology 

Administration (RITA), became the 

responsible DOT modal administration 

for implementing the F&OS program 

and requirements at 49 CFR part 1420. 

On September 29, 2004, the Secretary 

transferred the responsibility for the 

F&OS program from BTS, to FMCSA (69 

FR 51009). On August 10, 2006 (71 FR 

45740), the Secretary published a final 

rule that transferred and redesignated 

the motor carrier financial and 

statistical reporting regulations of BTS 

that were formerly located at chapter XI 

of title 49 CFR to FMCSA in 49 chapter 

III of title 49 CFR part 369. 

FMCSA plans to initiate a regulatory 

proceeding in the near future that will 

result in the elimination of two 

quarterly reporting requirements that 

are currently reported to OMB under the 

Paperwork Reduction Act (PRA) of 1995 

(44 U.S.C. 3501–3520). These forms 

include: (1) Form QFR Quarterly for 

property carriers, authorized by OMB 

under information collection 2126– 

0033; and (2) the Class I passenger 

carrier financial quarterly survey (MP– 

1 Quarterly), authorized by OMB under 

information collection 2126–0031. The 

FMCSA does not have the statutory 

authority to eliminate the annual 

reporting requirements for property or 

passengers. FMCSA will be publishing a 

direct final rule that will include 

additional information, including the 

reduced paperwork burden, resulting 

from this future action. 

Title: Annual and Quarterly Report of 

Class I Motor Carriers of Passengers 

(OMB 2139–0003). 

OMB Control Number: 2126–0031. 

Type of Request: Extension of a 

currently approved information 

collection request. 

Respondents: Class I Motor Carriers of 

Passengers. 

Estimated Number of Respondents: 2. 

Estimated Time per Response: 18 

minutes per response. 

Expiration Date: September 30, 2012. 

Frequency of Response: Annually and 

Quarterly. 

Estimated Total Annual Burden: 3 

hours [10 responses × 18 minutes per 

response/60 minutes]. 

Public Comments Invited: You are 

asked to comment on any aspect of this 

information collection, including: (1) 

Whether the proposed collection is 

necessary for the agency to perform its 

mission; (2) the accuracy of the 

estimated burden; (3) ways for FMCSA 

to enhance the quality, usefulness, and 

clarity of the collected information; and 

(4) ways that the burden could be 

minimized without reducing the quality 

of the collected information. The agency 

will summarize or include your 

comments in the request for OMB’s 

clearance of this information collection. 

Issued on: April 12, 2012. 

Kelly Leone, 

Associate Administrator for Office of 

Research and Information Technology. 

[FR Doc. 2012–9551 Filed 4–19–12; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[FMCSA–2012–0102] 

Proposed Recommendations on 

Obstructive Sleep Apnea 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice; request for public 

comments. 

SUMMARY: FMCSA announces proposed 

recommendations from the Motor 

Carrier Safety Advisory Committee 

(MCSAC) and the Medical Review 

Board (MRB) on Obstructive Sleep 

Apnea (OSA) and the medical 

certification of commercial motor 

vehicle (CMV) drivers. The MCSAC and 

the MRB are FMCSA advisory 

committees and operate in accordance 

with the Federal Advisory Committee 

Act (FACA). At the Agency’s request, 

the committees deliberated and 

provided their finalized 

recommendations to FMCSA on 

February 6, 2012. The Agency proposes 

to adopt the recommendations as 

regulatory guidance after reviewing and 

evaluating comments received from the 

public. 

DATES: Comments must be received on 

or before May 21, 2012. 

ADDRESSES: You may submit comments 

bearing the Federal Docket Management 

System (FDMS) Docket No. FMCSA 

2012–0102 using any of the following 

methods: 

• Federal eRulemaking Portal: Go to 

http://www.regulations.gov. Follow the 

on-line instructions for submitting 

comments. 

• Mail: Docket Management Facility; 

U.S. Department of Transportation, 1200 

New Jersey Avenue SE., West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery: West Building 

Ground Floor, Room W12–140, 1200 

New Jersey Avenue SE., Washington, 

DC, between 9 a.m. and 5 p.m., Monday 

through Friday, except Federal 

Holidays. 

• Fax: 1–202–493–2251. 

Instructions: Each submission must 

include the Agency name and the 

docket numbers for this notice. Note 

that all comments received will be 

posted without change to http:// 

www.regulations.gov, including any 

personal information provided. Please 

see the Privacy Act heading below for 

further information. 

Docket: For access to the docket to 

read background documents or 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 77 / Friday, April 20, 2012 / Notices 23795 

comments, go to http:// 

www.regulations.gov at any time or 

Room W12–140 on the ground level of 

the West Building, 1200 New Jersey 

Avenue SE., Washington, DC, between 9 

a.m. and 5 p.m., Monday through 

Friday, except Federal holidays. The 

FDMS is available 24 hours each day, 

365 days each year. If you want 

acknowledgment that we received your 

comments, please include a selfaddressed, stamped envelope or 

postcard or print the acknowledgment 

page that appears after submitting 

comments on-line. 

Privacy Act: Anyone may search the 

electronic form of all comments 

received into any of our dockets by the 

name of the individual submitting the 

comment (or of the person signing the 

comment, if submitted on behalf of an 

association, business, labor union, etc.). 

You may review DOT’s Privacy Act 

Statement for the FDMS published in 

the Federal Register on January 17, 

2008 (73 FR 3316), or you may visit 

http://edocket.access.gpo.gov/2008/pdf/ 

E8-785.pdf. 

FOR FURTHER INFORMATION CONTACT: 

Angela Ward, Nurse Consultant Medical 

Programs, (202) 366–4001, 

fmcsamedical@dot.gov, FMCSA, 

Department of Transportation, 1200 

New Jersey Avenue SE., Room W64– 

224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 

p.m., Monday through Friday, except 

Federal holidays. 

SUPPLEMENTARY INFORMATION: 

Background 

49 CFR 391.41(b)(5) provides that a 

person is qualified physically to drive a 

CMV if that person has no established 

medical history or clinical diagnosis of 

a respiratory dysfunction likely to 

interfere with the ability to control and 

drive a CMV safely. 

The Instructions to The Medical 

Examiner on the Medical Examination 

Report, (49 CFR 391.43), identifies OSA 

as one of several respiratory 

dysfunctions that may be detrimental to 

safe driving as this condition may 

interfere with driver alertness and may 

cause gradual or sudden incapacitation. 

FMCSA directed its two advisory 

committees, the MCSAC and the MRB, 

meet jointly and publically to deliberate 

on the topic of OSA and whether CMV 

drivers with OSA should be medically 

certified. 

FMCSA tasked the MCSAC and the 

MRB with jointly providing 

information, concepts, and ideas the 

Agency should consider in developing 

regulatory guidance for motor carriers, 

CMV drivers, and medical examiners on 

OSA and whether drivers with this 

condition should be medically certified 

to operate CMVs in interstate commerce. 

FMCSA instructed the MCSAC and 

MRB to provide information about how 

to address drivers with OSA in the 

short-term until the Agency can 

consider stategies for a long-term 

regulatory action. 

As part of the committees’ process for 

developing recommendations to be 

considered for regulatory guidance on 

OSA, the November 2007 Evidence 

Report was updated in November 2011 

and presented at the December 2011 

joint meeting of the MCSAC and the 

MRB. 

After the December 2011 joint 

MCSAC–MRB meeting, a MCSAC–MRB 

subcommittee was formed in 

accordance with FACA requirements. 

The subcommittee’s task was to bring 

recommendations back to the full joint 

committee for deliberation. The 

subcommittee met publicly on January 

4–5, 2012, to discuss this task and 

prepared recommendations for the full 

MCSAC’s and MRB’s consideration and 

deliberation at the February 2012 joint 

MCSAC–MRB meeting. In February 

2012 the joint committee deliberated 

and finalized its recommendations on 

OSA and medical certification of CMV 

drivers. 

Basis for Proposed Guidance on OSA 

The existing advisory criteria for the 

Respiratory Dysfunction requirement 

[391.41(b)(5)] states that ‘‘There are 

many conditions that interfere with 

oxygen exchange and may result in 

incapacitation, including [among others] 

sleep apnea. If the medical examiner 

detects a respiratory dysfunction, that in 

any way is likely to interfere with the 

driver’s ability to safely control and 

drive a commercial motor vehicle, the 

driver must be referred to a specialist for 

further evaluation and therapy.’’ 

Currently, FMCSA relies on medical 

examiners to apply professional 

judgment in applying FMCSA’s 

advisory criteria on OSA to determine 

whether a driver has a respiratory 

dysfunction such as OSA that may affect 

his or her ability to operate a CMV 

safely. The motor carrier community 

and medical examiners have requested 

that FMCSA improve the existing 

advisory criteria and provide more 

uniform regulatory guidance on OSA to 

the motor carrier industry and medical 

examiners. 

The Proposed Recommendations 

Introduction 

The MCSAC and MRB developed and 

discussed several key questions in 

considering Task 11–05 to provide 

information, concepts, and ideas 

FMCSA should consider in developing 

regulatory guidance for motor carriers, 

CMV drivers, and medical examiners on 

OSA and whether drivers with this 

condition should be medically certified 

to operate CMVs in interstate commerce. 

These questions are listed below. 

• Are individuals with OSA at an 

increased risk for a motor vehicle crash 

when compared to comparable 

individuals who do not have OSA? 

• What disease-related factors are 

associated with an increased motor 

vehicle crash risk among individuals 

with OSA? 

• Are individuals with OSA unaware 

of the presence of the factors that appear 

to be associated with an increased motor 

vehicle crash risk? 

• Are there screening/diagnostic tests 

available that will enable examiners to 

identify those individuals with OSA 

who are at an increased risk for a motor 

vehicle crash? 

• Which treatments have been shown 

to effectively reduce crash risk among 

individuals with OSA? 

• What is the length of time required 

following initiation of an effective 

treatment for individuals with OSA to 

reach a degree of improvement that 

would permit safe driving? 

• How soon following cessation of 

treatment will individuals with OSA 

demonstrate reduced driver safety (i.e., 

as a consequence of non-compliance)? 

Discussion of the above questions 

formed the basis of the joint MCSAC– 

MRB recommendations for 

consideration by FMCSA when 

developing regulatory guidance 

regarding OSA. The joint MCSAC–MRB 

recommendations are summarized 

below. 

I. General Recommendations Regarding 

OSA 

A. OSA diagnosis precludes 

unconditional certification. 

B. A driver with an OSA diagnosis 

may be certified if the following 

conditions are met: 

1. The driver has untreated OSA with 

an apnea-hypopnea index (AHI) of less 

than or equal to 20 (i.e., mild-tomoderate OSA), and 

2. The driver does not admit to 

experiencing excess sleepiness during 

the major wake period, or 

3. The driver’s OSA is being 

effectively treated. 

C. Notes on AHI threshold: 

1. The AHI threshold is used to 

prioritize drivers with OSA who need 

immediate treatment. 

2. The AHI threshold is set at 20 

because crash risk in the moderate-toVerDate Mar<15>2010 18:17 Apr 19, 2012 Jkt 226001 PO 00000 Frm 00138 Fmt 4703 Sfmt 4703 E:\FR\FM\20APN1.SGM 20APN1

tkelley on DSK3SPTVN1PROD with NOTICES
23796 Federal Register / Vol. 77, No. 77 / Friday, April 20, 2012 / Notices 

1Per 49 CFR 390.5, ‘‘accident’’ means (1) an 

occurrence involving a commercial motor vehicle 

operating on a highway in interstate or intrastate 

commerce which results in: (i) A fatality; (ii) Bodily 

injury to a person who, as a result of the injury, 

immediately receives medical treatment away from 

the scene of the accident; or (iii) One or more motor 

vehicles incurring disabling damage as a result of 

the accident, requiring the motor vehicle(s) to be 

transported away from the scene by a tow truck or 

other motor vehicle. 

severe OSA range is statistically higher 

than for drivers with mild OSA. 

3. Although an AHI of 15 is likely a 

safer threshold, there is no data to 

support this and such a threshold may 

be less practical in terms of enrolling 

patients for treatment. 

4. Drivers with mild OSA (AHI levels 

as low as 5) may benefit from OSA 

treatment, and should be encouraged to 

explore treatment options. 

5. Drivers with an AHI between 5 and 

20 should be encouraged to seek 

treatment if they have a history 

involving a fatigue-related crash or a 

DOT-defined single vehicle crash,1 or if 

they report sleepiness while operating a 

motor vehicle. 

D. A driver with an OSA diagnosis 

may be recertified annually, based on 

demonstrating compliance with 

treatment. 

1. Minimally acceptable compliance 

with Positive Airway Pressure (PAP) 

treatment consists of at least 4 hours per 

day of use on 70 percent of days. 

2. Drivers should be made aware that 

more hours of PAP use is preferable and 

that optimal treatment efficacy occurs 

with 7 or more hours of daily use during 

sleep. 

II. Immediate Disqualification or 

Certification Denial 

A. Drivers should be disqualified 

immediately or denied certification if 

any of the following conditions are met: 

1. The driver admits to experiencing 

excessive sleepiness during the major 

wake period while driving; or 

2. The driver experienced a crash 

associated with falling asleep; or 

3. The driver has been found noncompliant with treatment per 

Recommendation I.D. 

III. Conditional Certification 

A. Drivers may be granted conditional 

certification if any of the following 

conditions are met: 

1. The driver has an AHI of greater 

than 20 until compliant with PAP; or 

2. The driver has undergone surgery 

and is pending post-op findings per 

Recommendations VI–VIII; or 

3. The driver has a Body Mass Index 

(BMI) of greater than or equal to 

35 kg/m2 pending a sleep study. 

B. Notes on BMI threshold: 

1. The MRB is in agreement that a 

BMI threshold of 33 is supported by 

studies. 

2. MCSAC member Robert Petrancosta 

(Con-Way Freight) asserted that a BMI 

threshold should be objectively related 

to crash risk. 

C. Conditional certification should 

include the following elements: 

1. A driver with a BMI of greater than 

or equal to 35 kg/m2 may be certified for 

60 days pending sleep study and 

treatment (if the driver is diagnosed 

with OSA). 

2. Within 60 days, if a driver being 

treated with OSA is compliant with 

treatment (per Recommendations I.D. 

and V–IX), the driver may receive an 

additional 90-day conditional 

certification. 

3. After 90 days, if the driver is still 

compliant with treatment, the driver 

may be certified for no more than 1 year. 

Future certification should be 

dependent on continued compliance. 

D. OSA Screening (i.e., identifying 

individuals with undiagnosed OSA) 

1. In addition to a BMI of 35 or above, 

the following information may help a 

clinician diagnose OSA: 

a. Symptoms of OSA may include 

loud snoring, witnessed apneas, or 

sleepiness during the major wake 

period; 

b. Risk factors of OSA may include 

the following factors. However, a single 

risk factor alone may not infer risk, and 

a combination of multiple factors 

should be examined. 

i. Factors associated with high risk: 

—Small or recessed jaw 

—Small airway (Mallampati Scale score 

of Class 3 or 4) 

—Neck size (≥) 17 inches (male), 15.5 

inches (female) 

—Hypertension (treated or untreated) 

—Type 2 diabetes (treated or untreated) 

—Hypothyroidism (untreated) 

ii. Other factors: 

—BMI greater than or equal to 28 kg/m2

—Age 42 and above 

—Family history 

—Male or post-menopausal female 

—Experienced a single-vehicle crash 

IV. Method of Diagnosis and Severity 

A. Methods of diagnosis include inlaboratory polysomnography, at-home 

polysomnography, or an FDA-approved 

limited channel ambulatory testing 

device which ensures chain of custody. 

1. In-laboratory polysomnography, 

which is more comprehensive, should 

be considered when the clinician 

suspects another sleep disorder in 

addition to sleep apnea. 

2. New OSA screening technologies 

will likely emerge. 

B. The driver should be tested while 

on usual chronic medications. 

C. The MCSAC and MRB did not 

consider AHI levels from unattended 

(i.e., in-home) studies, only inlaboratory sleep studies that detect the 

arousal component of hypopneas, as 

well as saturation. 

1. An in-home sleep study may 

underestimate AHI when compared to 

an in-laboratory sleep study because the 

in-home study likely does not consider 

total sleep time. 

2. The medical examiner should use 

clinical judgment when interpreting the 

results of an unattended sleep study. 

a. If the clinician believes the level of 

apnea is greater than the level reported 

by the in-home study, the clinician 

should consider recommending an inlaboratory sleep study. 

V. Treatment: Positive Airway Pressure 

(PAP) 

A. All individuals with OSA should 

be referred to a clinician with relevant 

expertise. 

B. PAP is the preferred OSA therapy. 

C. Adequate PAP pressure should be 

established through one of the following 

methods: 

1. Titration study with 

polysomnography 

D. Auto-titration system 

A driver who has been disqualified 

may be conditionally certified (per 

Recommendation III) if the following 

conditions are met: 

1. The driver is successfully treated 

for one week; and 

2. The driver can demonstrate at least 

minimal compliance (i.e., 4 hours per 

use on 70 percent of nights); and 

3. The driver does not report 

excessive sleepiness during the major 

wake period. 

VI. Treatment: Bariatric Surgery 

A. After bariatric surgery, a driver 

may be certified if the following 

conditions are met: 

1. Six months have passed since the 

surgery (for weight loss); and 

2. The driver has been compliant with 

PAP for six months; and 

3. The driver has been cleared by the 

treating physician; and 

4. The driver does not report 

excessive sleepiness during the major 

wake period. 

B. After six months have passed since 

surgery, if the apnea appears to have 

resolved, a repeat sleep study should be 

considered to test for the presence of 

ongoing sleep apnea. 

C. Annual recertification: 

1. If clinically indicated, repeat the 

sleep study. 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 77 / Friday, April 20, 2012 / Notices 23797 

2Based on public comments received at the 

February MCSAC meeting, one member (Danny 

Schnautz, Clark Freight Lines, Inc., Pasadena, TX) 

suggested that the efficacy of dental appliances may 

need to be reviewed. 

VII. Treatment: Oropharyngeal Surgery, 

Facial Bone Surgery 

A. After oropharyngeal or facial bone 

surgery, a driver may be certified if the 

following conditions are met: 

1. One month has passed since 

surgery; and 

2. The driver has been cleared by the 

treating physician; and 

3. The driver does not report 

excessive sleepiness during the major 

wake period. 

B. After one month has passed since 

surgery, if the apnea appears to have 

resolved a repeat sleep study should be 

considered to test for the presence of 

ongoing sleep apnea. 

C. Annual recertification: 

1. If clinically indicated, repeat the 

sleep study. 

VIII. Treatment: Tracheostomy 

A. After a tracheostomy, a driver may 

be certified if the following conditions 

are met: 

1. One month has passed since 

surgery; and 

2. The driver has been cleared by the 

treating physician; and 

3. The driver does not report 

excessive sleepiness during the major 

wake period. 

B. After one month has passed since 

surgery, if the apnea appears to have 

resolved a repeat sleep study should be 

considered to test for the presence of 

ongoing sleep apnea. 

C. Annual recertification: 

1. If clinically indicated, repeat the 

sleep study. 

IX. Treatment Alternatives 

A. There is limited data regarding 

compliance and long-term efficacy of 

dental appliances and these 

technologies are not approved 

alternatives at this time.2

B. Surgical treatment is acceptable 

(See Recommendations VI–VIII). 

Request for Comments 

FMCSA requests comments on the 

above joint recommendations provided 

to the Agency by its Motor Carrier 

Safety Advisory Committee and Medical 

Review Board on Obstructive Sleep 

Apnea. Commenters are requested to 

provide supporting data wherever 

appropriate. 

The Agency will consider all 

comments received before the close of 

business May 21, 2012. Comments will 

be available for examination in the 

docket at the location listed under the 

ADDRESSES section of this notice. The 

Agency will file comments received 

after the comment closing date in the 

public docket, and will consider them to 

the extent practicable. In addition to late 

comments, FMCSA will also continue to 

file, in the public docket, relevant 

information that becomes available after 

the comment closing date. Interested 

persons should monitor the public 

docket for new material. 

Issued on: April 16, 2012. 

Larry W. Minor, 

Associate Administrator of Policy. 

[FR Doc. 2012–9555 Filed 4–19–12; 8:45 am] 

BILLING CODE 4910–EX–P 

DEPARTMENT OF TRANSPORTATION 

Federal Motor Carrier Safety 

Administration 

[Docket No. FMCSA–1999–6480; FMCSA– 

2001–11426; FMCSA–2002–12844; FMCSA– 

2003–16564; FMCSA–2005–21711; FMCSA– 

2005–22727; FMCSA–2006–23773; FMCSA– 

2007–0017; FMCSA–2008–0021; FMCSA– 

2009–0303; FMCSA–2009–0291] 

Qualification of Drivers; Exemption 

Applications; Vision 

AGENCY: Federal Motor Carrier Safety 

Administration (FMCSA), DOT. 

ACTION: Notice of renewal of 

exemptions; request for comments. 

SUMMARY: FMCSA announces its 

decision to renew the exemptions from 

the vision requirement in the Federal 

Motor Carrier Safety Regulations for 29 

individuals. FMCSA has statutory 

authority to exempt individuals from 

the vision requirement if the 

exemptions granted will not 

compromise safety. The Agency has 

concluded that granting these 

exemption renewals will provide a level 

of safety that is equivalent to or greater 

than the level of safety maintained 

without the exemptions for these 

commercial motor vehicle (CMV) 

drivers. 

DATES: This decision is effective May 

12, 2012. Comments must be received 

on or before May 21, 2012. 

ADDRESSES: You may submit comments 

bearing the Federal Docket Management 

System (FDMS) numbers: FMCSA– 

1999–6480; FMCSA–2001–11426; 

FMCSA–2002–12844; FMCSA–2003– 

16564; FMCSA–2005–21711; FMCSA– 

2005–22727; FMCSA–2006–23773; 

FMCSA–2007–0017; FMCSA–2008– 

0021; FMCSA–2009–0303; FMCSA– 

2009–0291, using any of the following 

methods: 

• Federal eRulemaking Portal: Go to 

http://www.regulations.gov. Follow the 

on-line instructions for submitting 

comments. 

• Mail: Docket Management Facility; 

U.S. Department of Transportation, 1200 

New Jersey Avenue SE., West Building 

Ground Floor, Room W12–140, 

Washington, DC 20590–0001. 

• Hand Delivery or Courier: West 

Building Ground Floor, Room W12–140, 

1200 New Jersey Avenue SE., 

Washington, DC, between 9 a.m. and 

5 p.m., Monday through Friday, except 

Federal holidays. 

• Fax: 1–202–493–2251. 

Instructions: Each submission must 

include the Agency name and the 

docket number for this notice. Note that 

DOT posts all comments received 

without change to http:// 

www.regulations.gov, including any 

personal information included in a 

comment. Please see the Privacy Act 

heading below. 

Docket: For access to the docket to 

read background documents or 

comments, go to http:// 

www.regulations.gov at any time or 

Room W12–140 on the ground level of 

the West Building, 1200 New Jersey 

Avenue SE., Washington, DC, between 

9 a.m. and 5 p.m., Monday through 

Friday, except Federal holidays. The 

Federal Docket Management System 

(FDMS) is available 24 hours each day, 

365 days each year. If you want 

acknowledgment that we received your 

comments, please include a selfaddressed, stamped envelope or 

postcard or print the acknowledgement 

page that appears after submitting 

comments on-line. 

Privacy Act: Anyone may search the 

electronic form of all comments 

received into any of our dockets by the 

name of the individual submitting the 

comment (or of the person signing the 

comment, if submitted on behalf of an 

association, business, labor union, etc.). 

You may review DOT’s Privacy Act 

Statement for the FDMS published in 

the Federal Register on January 17, 

2008 (73 FR 3316), or you may visit 

http://edocket.access.gpo.gov/2008/pdf/ 

E8-785.pdf. 

FOR FURTHER INFORMATION CONTACT: 

Elaine M. Papp, Chief, Medical 

Programs Division, 202–366–4001, 

fmcsamedical@dot.gov, FMCSA, 

Department of Transportation, 1200 

New Jersey Avenue SE., Room W64– 

224, Washington, DC 20590–0001. 

Office hours are from 8:30 a.m. to 5 p.m. 

Monday through Friday, except Federal 

holidays. 

SUPPLEMENTARY INFORMATION: 


tkelley on DSK3SPTVN1PROD with NOTICES